Back

Comparison of FFR-angio and non-hyperemic pressure ratios in patients with aortic stenosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Chronic coronary syndromes: intracoronary diagnosis Coronary Circulation, Flow, and Flow Reserve ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ryoto Inaba

Sakakibara Heart Institute, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
FFR-guided complete revascularization vs culprit-only primary PCI among hemodynamically stable STEMI patients with multivessel disease: a meta-analysis
Doctor J. Isanan (Cebu City, PH)
Abstract Slides Video
Presentation thumbnail
The prognostic relevance of delta fractional flow ratio and delta quantitative flow ratio in cardiovascular outcomes
Doctor B. Csanadi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Sex-stratified analysis of the Functional FFRCT Score distribution and prognostic value in the FORECAST cohort
Doctor L. Gabara (Southampton, GB)
Abstract Slides Video
Presentation thumbnail
CCTA and FFR-CT: foes or friends in detecting significant lesions in high-risk NSTE-ACS patients?
Miss A. Zimmerli (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of combined endothelium-dependent and endothelium-independent coronary flow reserve on cardiovascular outcomes
Doctor K. Nogami (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes: intracoronary diagnosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
iFR vs. FFR for coronary revascularization: safety and outcomes
thumbnail
Congress Presentation
The effect of transcatheter aortic valve implantation on fractional flow reserve and non-hyperemic pressure ratios
thumbnail
Congress Presentation
Impact of fractional flow reserve measurement on angina frequency in the invasive arm of the ISCHEMIA trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources